Whales with a lot of money to spend have taken a noticeably bullish stance on Moderna.
Looking at options history for Moderna MRNA we detected 26 trades.
If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened trades with bullish expectations and 38% with bearish.
From the overall spotted trades, 9 are puts, for a total amount of $1,549,640 and 17, calls, for a total amount of $974,753.
Expected Price Movements
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $30.0 to $140.0 for Moderna over the last 3 months.
Volume & Open Interest Development
In terms of liquidity and interest, the mean open interest for Moderna options trades today is 982.53 with a total volume of 5,971.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Moderna's big money trades within a strike price range of $30.0 to $140.0 over the last 30 days.
Moderna Option Volume And Open Interest Over Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRNA | PUT | TRADE | NEUTRAL | 01/16/26 | $6.5 | $4.25 | $5.2 | $30.00 | $780.0K | 6.0K | 1.5K |
| MRNA | PUT | SWEEP | BEARISH | 02/07/25 | $1.6 | $1.58 | $1.6 | $38.00 | $329.2K | 881 | 4 |
| MRNA | CALL | TRADE | BEARISH | 01/16/26 | $10.5 | $10.25 | $10.25 | $40.00 | $203.9K | 1.6K | 3 |
| MRNA | CALL | SWEEP | BULLISH | 06/20/25 | $4.65 | $4.6 | $4.65 | $45.00 | $139.5K | 2.1K | 82 |
| MRNA | PUT | TRADE | BEARISH | 06/20/25 | $102.95 | $102.25 | $102.69 | $140.00 | $92.4K | 59 | 1 |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Present Market Standing of Moderna
- With a volume of 4,167,881, the price of MRNA is down -5.18% at $37.38.
- RSI indicators hint that the underlying stock may be approaching oversold.
- Next earnings are expected to be released in 11 days.
Professional Analyst Ratings for Moderna
5 market experts have recently issued ratings for this stock, with a consensus target price of $66.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * An analyst from Goldman Sachs has revised its rating downward to Neutral, adjusting the price target to $51. * An analyst from UBS persists with their Buy rating on Moderna, maintaining a target price of $96. * An analyst from Evercore ISI Group persists with their In-Line rating on Moderna, maintaining a target price of $50. * Consistent in their evaluation, an analyst from Goldman Sachs keeps a Buy rating on Moderna with a target price of $99. * Maintaining their stance, an analyst from Morgan Stanley continues to hold a Equal-Weight rating for Moderna, targeting a price of $38.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Moderna, Benzinga Pro gives you real-time options trades alerts.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
